Differential_JJ
nuclear_JJ
localization_NN
of_IN
p50_NN
,_,
p52_NN
,_,
and_CC
RelB_NN
proteins_NNS
in_IN
human_JJ
accessory_JJ
cells_NNS
of_IN
the_DT
immune_JJ
response_NN
in_FW
situ_FW
._.

The_DT
Rel\/NF-kappa_NN
B_NN
proteins_NNS
,_,
p50_NN
,_,
p52_NN
,_,
p65_NN
,_,
c-Rel_NN
,_,
and_CC
RelB_NN
,_,
constitute_VBP
a_DT
family_NN
of_IN
transcription_NN
factors_NNS
involved_VBN
in_IN
the_DT
positive_JJ
regulation_NN
of_IN
a_DT
variety_NN
of_IN
genes_NNS
during_IN
the_DT
immune_JJ
response_NN
._.

Recently_RB
,_,
it_PRP
has_VBZ
been_VBN
shown_VBN
that_IN
RelB_NN
knockout_JJ
mice_NNS
have_VBP
no_DT
dendritic_JJ
cells_NNS
-LRB-_-LRB-
DC_NN
-RRB-_-RRB-
._.

An_DT
overexpression_NN
of_IN
p50_NN
has_VBZ
been_VBN
described_VBN
in_IN
follicular_JJ
dendritic_JJ
cells_NNS
-LRB-_-LRB-
FDC_NN
-RRB-_-RRB-
._.

A_DT
constitutive_JJ
NF-kappa_NN
B_NN
activity_NN
has_VBZ
been_VBN
reported_VBN
in_IN
mature_JJ
macrophages_NNS
._.

This_DT
led_VBD
to_TO
the_DT
hypothesis_NN
that_IN
some_DT
of_IN
the_DT
Rel\/NF-kappa_NN
B_NN
proteins_NNS
were_VBD
key_JJ
nuclear_JJ
factors_NNS
in_IN
functions_NNS
of_IN
accessory_JJ
cells_NNS
of_IN
the_DT
immune_JJ
response_NN
._.

Therefore_RB
,_,
we_PRP
investigated_VBD
in_FW
situ_FW
the_DT
nuclear_JJ
localization_NN
of_IN
Rel\/NF-kappa_NN
B_NN
proteins_NNS
in_IN
accessory_JJ
cells_NNS
of_IN
the_DT
immune_JJ
system_NN
by_IN
immunohistochemistry_NN
and_CC
double_JJ
labeling_NN
by_IN
immunofluorescence_NN
from_IN
five_CD
normal_JJ
human_JJ
tonsils_NNS
and_CC
five_CD
lymph_NN
nodes_NNS
with_IN
follicular_JJ
hyperplasia_NN
._.

Nuclear_JJ
p65_NN
and_CC
c-Rel_NN
proteins_NNS
were_VBD
found_VBN
in_IN
all_DT
cell_NN
types_NNS
including_VBG
lymphocytes_NNS
._.

In_IN
germinal_JJ
centers_NNS
GC_NN
,_,
p50_NN
,_,
p52_NN
,_,
and_CC
RelB_NN
were_VBD
found_VBN
in_IN
the_DT
nuclei_NNS
of_IN
FDC_NN
only_RB
and_CC
were_VBD
not_RB
detected_VBN
in_IN
the_DT
nuclei_NNS
of_IN
CD68_NN
+_CC
cells_NNS
._.

In_IN
T_NN
cell_NN
areas_NNS
,_,
p50_NN
,_,
p52_NN
,_,
and_CC
RelB_NN
were_VBD
found_VBN
in_IN
the_DT
nuclei_NNS
of_IN
HLA-DR_NN
+_CC
cells_NNS
with_IN
an_DT
antigen-presenting_JJ
cell_NN
-LRB-_-LRB-
APC_NN
-RRB-_-RRB-
morphology_NN
._.

p52_NN
and_CC
RelB_NN
were_VBD
detected_VBN
in_IN
the_DT
nuclei_NNS
in_IN
both_CC
CD1a_NN
+_CC
and_CC
CD68_NN
+_CC
cells_NNS
from_IN
the_DT
T_NN
cell_NN
area_NN
,_,
whereas_IN
p50_NN
was_VBD
found_VBN
only_RB
in_IN
CD68_NN
-_:
and_CC
CD1a_NN
-_:
cells_NNS
._.

Cells_NNS
with_IN
nuclear_JJ
p50_NN
were_VBD
negative_JJ
for_IN
the_DT
CD38_NN
,_,
CD20_NN
and_CC
CD2_NN
markers_NNS
._.

These_DT
results_NNS
show_VBP
that_IN
,_,
physiologically_RB
,_,
high_JJ
levels_NNS
of_IN
nuclear_JJ
of_IN
p50_NN
,_,
p52_NN
and_CC
RelB_NN
are_VBP
restricted_JJ
to_TO
accessory_JJ
cells_NNS
of_IN
the_DT
immune_JJ
system_NN
,_,
which_WDT
include_VBP
FDC_NN
in_IN
GC_NN
,_,
and_CC
DC_NN
and_CC
macrophages_NNS
in_IN
the_DT
T_NN
cell_NN
zone_NN
,_,
that_IN
specialized_VBN
scavenger_NN
macrophages_NNS
from_IN
GC_NN
do_VBP
not_RB
have_VB
detectable_JJ
levels_NNS
of_IN
p52_NN
and_CC
RelB_NN
,_,
whereas_IN
macrophages_NNS
from_IN
the_DT
T_NN
cell_NN
area_NN
,_,
known_VBN
to_TO
present_VB
the_DT
antigen_NN
to_TO
T_NN
cells_NNS
,_,
do_VBP
have_VB
both_CC
nuclear_JJ
p52_NN
and_CC
RelB_NN
,_,
and_CC
that_IN
in_IN
the_DT
T_NN
cell_NN
zone_NN
,_,
p52_NN
and_CC
RelB_NN
are_VBP
located_JJ
in_IN
nuclei_NNS
of_IN
both_CC
CD1a_NNP
+_NNP
,_,
CD68_NN
+_NN
or_CC
both_DT
,_,
cells_NNS
APC_NN
,_,
whereas_IN
p50_NN
is_VBZ
restricted_JJ
to_TO
CD1a_NN
-_:
and_CC
CD68_NN
-_:
APC_NN
._.

The_DT
different_JJ
patterns_NNS
of_IN
p50_NN
,_,
p52_NN
and_CC
RelB_NN
protein_NN
nuclear_JJ
localization_NN
may_MD
provide_VB
insight_NN
into_IN
their_PRP$
different_JJ
roles_NNS
during_IN
the_DT
immune_JJ
response_NN
in_FW
vivo_FW
._.

